Skip to main content
. Author manuscript; available in PMC: 2020 Jun 3.
Published in final edited form as: JACC Clin Electrophysiol. 2017 Aug 30;3(11):1308–1317. doi: 10.1016/j.jacep.2017.05.004

TABLE 1.

Patient Characteristics (N = 80)

Male, % 42 (53%)

Age at first symptom, yrs 11.0 (6.0-13.0)

Age at diagnosis, yrs 11.0 (7.4-14.0)

Follow-up, yrs 6.4 (2.2-10.0)

Proband 66 (83)

Family history of CPVT 19 (24)

History of cardiac arrest 29 (36)

Positive genetic testing 49 (80)

RyR2 45 (92)

CASQ2 2 (4)
KCNJ2 2 (4)

Antiarrhythmic
 β anti-adrenergic blocker 78 (98)
 Flecainide 15 (19)
 Calcium channel blocker 12 (15)

ICD (n = 49)
 Age at implantation, yrs 13.5 (9.3-16.7)
 ICD follow up 9.0 (6.0-12.1)
 Dual chamber 26 (53)
 Left cardiac sympathetic denervation 15 (19)

Deaths 3 (4)

Values are n (%) or median (interquartile range).

CPVT = catechotaminergic polymorphic ventricular tachycardia; ICD = implantable cardioverter defibrillator.